nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—Microtubule Inhibition—Docetaxel—skin cancer	0.734	1	CiPCiCtD
Griseofulvin—CYP1A2—Imiquimod—skin cancer	0.0497	0.249	CbGbCtD
Griseofulvin—KRT12—eyelid—skin cancer	0.0315	0.92	CbGeAlD
Griseofulvin—CYP1A2—Vemurafenib—skin cancer	0.0272	0.137	CbGbCtD
Griseofulvin—CYP3A4—Imiquimod—skin cancer	0.026	0.131	CbGbCtD
Griseofulvin—CYP3A4—Temozolomide—skin cancer	0.026	0.131	CbGbCtD
Griseofulvin—CYP1A2—Dacarbazine—skin cancer	0.0209	0.105	CbGbCtD
Griseofulvin—CYP3A4—Vismodegib—skin cancer	0.018	0.0905	CbGbCtD
Griseofulvin—CYP3A4—Vemurafenib—skin cancer	0.0143	0.0716	CbGbCtD
Griseofulvin—CYP1A2—Fluorouracil—skin cancer	0.0122	0.0614	CbGbCtD
Griseofulvin—CYP3A4—Docetaxel—skin cancer	0.00489	0.0246	CbGbCtD
Griseofulvin—KRT12—head—skin cancer	0.00199	0.0581	CbGeAlD
Griseofulvin—Hepatic enzyme increased—Vismodegib—skin cancer	0.00153	0.0465	CcSEcCtD
Griseofulvin—Proteinuria—Imiquimod—skin cancer	0.000867	0.0263	CcSEcCtD
Griseofulvin—Protein urine present—Imiquimod—skin cancer	0.000855	0.026	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Imiquimod—skin cancer	0.000805	0.0245	CcSEcCtD
Griseofulvin—Oral candidiasis—Temozolomide—skin cancer	0.000718	0.0218	CcSEcCtD
Griseofulvin—Coagulopathy—Dactinomycin—skin cancer	0.000648	0.0197	CcSEcCtD
Griseofulvin—Coagulopathy—Temozolomide—skin cancer	0.000586	0.0178	CcSEcCtD
Griseofulvin—CYP1A2—nipple—skin cancer	0.000558	0.0163	CbGeAlD
Griseofulvin—Systemic lupus erythematosus—Docetaxel—skin cancer	0.000548	0.0167	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Temozolomide—skin cancer	0.000502	0.0153	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vemurafenib—skin cancer	0.00049	0.0149	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Temozolomide—skin cancer	0.000483	0.0147	CcSEcCtD
Griseofulvin—Oral candidiasis—Docetaxel—skin cancer	0.000478	0.0145	CcSEcCtD
Griseofulvin—Dyspepsia—Vismodegib—skin cancer	0.000454	0.0138	CcSEcCtD
Griseofulvin—Fatigue—Vismodegib—skin cancer	0.000445	0.0135	CcSEcCtD
Griseofulvin—Candida infection—Temozolomide—skin cancer	0.000436	0.0132	CcSEcCtD
Griseofulvin—Neuropathy—Temozolomide—skin cancer	0.000429	0.013	CcSEcCtD
Griseofulvin—Erythema multiforme—Vemurafenib—skin cancer	0.000424	0.0129	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Imiquimod—skin cancer	0.000418	0.0127	CcSEcCtD
Griseofulvin—Erythema—Vemurafenib—skin cancer	0.00039	0.0119	CcSEcCtD
Griseofulvin—Asthenia—Vismodegib—skin cancer	0.00037	0.0112	CcSEcCtD
Griseofulvin—Erythema multiforme—Imiquimod—skin cancer	0.000362	0.011	CcSEcCtD
Griseofulvin—Diarrhoea—Vismodegib—skin cancer	0.000353	0.0107	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Docetaxel—skin cancer	0.000334	0.0101	CcSEcCtD
Griseofulvin—Erythema—Imiquimod—skin cancer	0.000333	0.0101	CcSEcCtD
Griseofulvin—Vomiting—Vismodegib—skin cancer	0.000328	0.00997	CcSEcCtD
Griseofulvin—Rash—Vismodegib—skin cancer	0.000325	0.00988	CcSEcCtD
Griseofulvin—Dermatitis—Vismodegib—skin cancer	0.000325	0.00987	CcSEcCtD
Griseofulvin—Nausea—Vismodegib—skin cancer	0.000306	0.00931	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000305	0.00928	CcSEcCtD
Griseofulvin—Angioedema—Imiquimod—skin cancer	0.000304	0.00925	CcSEcCtD
Griseofulvin—Candida infection—Docetaxel—skin cancer	0.00029	0.00881	CcSEcCtD
Griseofulvin—Neuropathy—Docetaxel—skin cancer	0.000285	0.00866	CcSEcCtD
Griseofulvin—Fatigue—Vemurafenib—skin cancer	0.000275	0.00835	CcSEcCtD
Griseofulvin—Agranulocytosis—Dactinomycin—skin cancer	0.000263	0.00801	CcSEcCtD
Griseofulvin—Hepatitis—Dactinomycin—skin cancer	0.000253	0.0077	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Temozolomide—skin cancer	0.00025	0.00761	CcSEcCtD
Griseofulvin—Insomnia—Imiquimod—skin cancer	0.000246	0.00747	CcSEcCtD
Griseofulvin—Paraesthesia—Imiquimod—skin cancer	0.000244	0.00742	CcSEcCtD
Griseofulvin—Erythema multiforme—Dactinomycin—skin cancer	0.00024	0.00728	CcSEcCtD
Griseofulvin—Dyspepsia—Imiquimod—skin cancer	0.000239	0.00727	CcSEcCtD
Griseofulvin—Erythema—Bleomycin—skin cancer	0.000237	0.00719	CcSEcCtD
Griseofulvin—Hypersensitivity—Vemurafenib—skin cancer	0.000235	0.00714	CcSEcCtD
Griseofulvin—Fatigue—Imiquimod—skin cancer	0.000234	0.00712	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Fluorouracil—skin cancer	0.000231	0.00701	CcSEcCtD
Griseofulvin—Hepatitis—Temozolomide—skin cancer	0.000229	0.00697	CcSEcCtD
Griseofulvin—Asthenia—Vemurafenib—skin cancer	0.000229	0.00695	CcSEcCtD
Griseofulvin—Feeling abnormal—Imiquimod—skin cancer	0.000224	0.00681	CcSEcCtD
Griseofulvin—Erythema—Dactinomycin—skin cancer	0.000221	0.00671	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00022	0.0067	CcSEcCtD
Griseofulvin—Agranulocytosis—Fluorouracil—skin cancer	0.00022	0.00667	CcSEcCtD
Griseofulvin—Diarrhoea—Vemurafenib—skin cancer	0.000218	0.00663	CcSEcCtD
Griseofulvin—Erythema multiforme—Temozolomide—skin cancer	0.000217	0.00659	CcSEcCtD
Griseofulvin—Urticaria—Imiquimod—skin cancer	0.000216	0.00656	CcSEcCtD
Griseofulvin—Leukopenia—Bleomycin—skin cancer	0.000212	0.00644	CcSEcCtD
Griseofulvin—Dizziness—Vemurafenib—skin cancer	0.000211	0.0064	CcSEcCtD
Griseofulvin—Vomiting—Vemurafenib—skin cancer	0.000203	0.00616	CcSEcCtD
Griseofulvin—CYP3A4—female reproductive system—skin cancer	0.000202	0.00591	CbGeAlD
Griseofulvin—Rash—Vemurafenib—skin cancer	0.000201	0.00611	CcSEcCtD
Griseofulvin—Dermatitis—Vemurafenib—skin cancer	0.000201	0.0061	CcSEcCtD
Griseofulvin—Hypersensitivity—Imiquimod—skin cancer	0.0002	0.00609	CcSEcCtD
Griseofulvin—Headache—Vemurafenib—skin cancer	0.0002	0.00607	CcSEcCtD
Griseofulvin—Erythema—Temozolomide—skin cancer	0.0002	0.00606	CcSEcCtD
Griseofulvin—Leukopenia—Dactinomycin—skin cancer	0.000197	0.006	CcSEcCtD
Griseofulvin—Asthenia—Imiquimod—skin cancer	0.000195	0.00593	CcSEcCtD
Griseofulvin—Confusional state—Bleomycin—skin cancer	0.000195	0.00592	CcSEcCtD
Griseofulvin—Nausea—Vemurafenib—skin cancer	0.000189	0.00575	CcSEcCtD
Griseofulvin—Diarrhoea—Imiquimod—skin cancer	0.000186	0.00565	CcSEcCtD
Griseofulvin—Erythema—Fluorouracil—skin cancer	0.000184	0.00559	CcSEcCtD
Griseofulvin—Angioedema—Temozolomide—skin cancer	0.000182	0.00554	CcSEcCtD
Griseofulvin—Dizziness—Imiquimod—skin cancer	0.00018	0.00546	CcSEcCtD
Griseofulvin—Leukopenia—Temozolomide—skin cancer	0.000179	0.00543	CcSEcCtD
Griseofulvin—Paraesthesia—Bleomycin—skin cancer	0.000173	0.00527	CcSEcCtD
Griseofulvin—Vomiting—Imiquimod—skin cancer	0.000173	0.00525	CcSEcCtD
Griseofulvin—Rash—Imiquimod—skin cancer	0.000171	0.00521	CcSEcCtD
Griseofulvin—Dermatitis—Imiquimod—skin cancer	0.000171	0.0052	CcSEcCtD
Griseofulvin—Headache—Imiquimod—skin cancer	0.00017	0.00517	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Docetaxel—skin cancer	0.000166	0.00506	CcSEcCtD
Griseofulvin—Leukopenia—Fluorouracil—skin cancer	0.000165	0.005	CcSEcCtD
Griseofulvin—Confusional state—Temozolomide—skin cancer	0.000164	0.00499	CcSEcCtD
Griseofulvin—Nausea—Imiquimod—skin cancer	0.000161	0.00491	CcSEcCtD
Griseofulvin—Feeling abnormal—Bleomycin—skin cancer	0.000159	0.00484	CcSEcCtD
Griseofulvin—Agranulocytosis—Docetaxel—skin cancer	0.000158	0.00482	CcSEcCtD
Griseofulvin—Fatigue—Dactinomycin—skin cancer	0.000155	0.00472	CcSEcCtD
Griseofulvin—Urticaria—Bleomycin—skin cancer	0.000153	0.00466	CcSEcCtD
Griseofulvin—Hepatitis—Docetaxel—skin cancer	0.000152	0.00463	CcSEcCtD
Griseofulvin—Confusional state—Fluorouracil—skin cancer	0.000151	0.0046	CcSEcCtD
Griseofulvin—Feeling abnormal—Dactinomycin—skin cancer	0.000148	0.00451	CcSEcCtD
Griseofulvin—Insomnia—Temozolomide—skin cancer	0.000147	0.00448	CcSEcCtD
Griseofulvin—Paraesthesia—Temozolomide—skin cancer	0.000146	0.00444	CcSEcCtD
Griseofulvin—Erythema multiforme—Docetaxel—skin cancer	0.000144	0.00438	CcSEcCtD
Griseofulvin—Dyspepsia—Temozolomide—skin cancer	0.000143	0.00436	CcSEcCtD
Griseofulvin—Hypersensitivity—Bleomycin—skin cancer	0.000142	0.00432	CcSEcCtD
Griseofulvin—Fatigue—Temozolomide—skin cancer	0.00014	0.00427	CcSEcCtD
Griseofulvin—Asthenia—Bleomycin—skin cancer	0.000138	0.00421	CcSEcCtD
Griseofulvin—Insomnia—Fluorouracil—skin cancer	0.000136	0.00412	CcSEcCtD
Griseofulvin—Paraesthesia—Fluorouracil—skin cancer	0.000135	0.00409	CcSEcCtD
Griseofulvin—Feeling abnormal—Temozolomide—skin cancer	0.000134	0.00408	CcSEcCtD
Griseofulvin—Erythema—Docetaxel—skin cancer	0.000133	0.00403	CcSEcCtD
Griseofulvin—Hypersensitivity—Dactinomycin—skin cancer	0.000133	0.00403	CcSEcCtD
Griseofulvin—Dyspepsia—Fluorouracil—skin cancer	0.000132	0.00401	CcSEcCtD
Griseofulvin—Urticaria—Temozolomide—skin cancer	0.000129	0.00393	CcSEcCtD
Griseofulvin—Asthenia—Dactinomycin—skin cancer	0.000129	0.00393	CcSEcCtD
Griseofulvin—Feeling abnormal—Fluorouracil—skin cancer	0.000124	0.00376	CcSEcCtD
Griseofulvin—Diarrhoea—Dactinomycin—skin cancer	0.000123	0.00374	CcSEcCtD
Griseofulvin—Vomiting—Bleomycin—skin cancer	0.000123	0.00373	CcSEcCtD
Griseofulvin—Rash—Bleomycin—skin cancer	0.000122	0.0037	CcSEcCtD
Griseofulvin—Dermatitis—Bleomycin—skin cancer	0.000122	0.0037	CcSEcCtD
Griseofulvin—Hypersensitivity—Temozolomide—skin cancer	0.00012	0.00365	CcSEcCtD
Griseofulvin—Urticaria—Fluorouracil—skin cancer	0.000119	0.00362	CcSEcCtD
Griseofulvin—Leukopenia—Docetaxel—skin cancer	0.000119	0.00361	CcSEcCtD
Griseofulvin—Asthenia—Temozolomide—skin cancer	0.000117	0.00355	CcSEcCtD
Griseofulvin—Nausea—Bleomycin—skin cancer	0.000115	0.00349	CcSEcCtD
Griseofulvin—Vomiting—Dactinomycin—skin cancer	0.000114	0.00348	CcSEcCtD
Griseofulvin—Rash—Dactinomycin—skin cancer	0.000114	0.00345	CcSEcCtD
Griseofulvin—Diarrhoea—Temozolomide—skin cancer	0.000111	0.00339	CcSEcCtD
Griseofulvin—Hypersensitivity—Fluorouracil—skin cancer	0.000111	0.00336	CcSEcCtD
Griseofulvin—Confusional state—Docetaxel—skin cancer	0.000109	0.00332	CcSEcCtD
Griseofulvin—Dizziness—Temozolomide—skin cancer	0.000108	0.00327	CcSEcCtD
Griseofulvin—Nausea—Dactinomycin—skin cancer	0.000107	0.00325	CcSEcCtD
Griseofulvin—Vomiting—Temozolomide—skin cancer	0.000104	0.00315	CcSEcCtD
Griseofulvin—Rash—Temozolomide—skin cancer	0.000103	0.00312	CcSEcCtD
Griseofulvin—Diarrhoea—Fluorouracil—skin cancer	0.000103	0.00312	CcSEcCtD
Griseofulvin—Dermatitis—Temozolomide—skin cancer	0.000103	0.00312	CcSEcCtD
Griseofulvin—Headache—Temozolomide—skin cancer	0.000102	0.0031	CcSEcCtD
Griseofulvin—Dizziness—Fluorouracil—skin cancer	9.92e-05	0.00302	CcSEcCtD
Griseofulvin—Insomnia—Docetaxel—skin cancer	9.79e-05	0.00298	CcSEcCtD
Griseofulvin—Paraesthesia—Docetaxel—skin cancer	9.72e-05	0.00296	CcSEcCtD
Griseofulvin—Nausea—Temozolomide—skin cancer	9.67e-05	0.00294	CcSEcCtD
Griseofulvin—Vomiting—Fluorouracil—skin cancer	9.54e-05	0.0029	CcSEcCtD
Griseofulvin—Dyspepsia—Docetaxel—skin cancer	9.53e-05	0.0029	CcSEcCtD
Griseofulvin—Rash—Fluorouracil—skin cancer	9.46e-05	0.00288	CcSEcCtD
Griseofulvin—Dermatitis—Fluorouracil—skin cancer	9.45e-05	0.00287	CcSEcCtD
Griseofulvin—Headache—Fluorouracil—skin cancer	9.4e-05	0.00286	CcSEcCtD
Griseofulvin—Fatigue—Docetaxel—skin cancer	9.34e-05	0.00284	CcSEcCtD
Griseofulvin—Feeling abnormal—Docetaxel—skin cancer	8.92e-05	0.00271	CcSEcCtD
Griseofulvin—Nausea—Fluorouracil—skin cancer	8.91e-05	0.00271	CcSEcCtD
Griseofulvin—Hypersensitivity—Docetaxel—skin cancer	7.98e-05	0.00243	CcSEcCtD
Griseofulvin—Asthenia—Docetaxel—skin cancer	7.77e-05	0.00236	CcSEcCtD
Griseofulvin—Diarrhoea—Docetaxel—skin cancer	7.41e-05	0.00225	CcSEcCtD
Griseofulvin—Dizziness—Docetaxel—skin cancer	7.16e-05	0.00218	CcSEcCtD
Griseofulvin—Vomiting—Docetaxel—skin cancer	6.88e-05	0.00209	CcSEcCtD
Griseofulvin—Rash—Docetaxel—skin cancer	6.83e-05	0.00208	CcSEcCtD
Griseofulvin—Dermatitis—Docetaxel—skin cancer	6.82e-05	0.00207	CcSEcCtD
Griseofulvin—Headache—Docetaxel—skin cancer	6.78e-05	0.00206	CcSEcCtD
Griseofulvin—Nausea—Docetaxel—skin cancer	6.43e-05	0.00196	CcSEcCtD
